Further supporting these observations, Pillinger et al. (2017) synthesized data from 16 case-control studies and found that antipsychotic-naive patients with first-episode schizophrenia had significantly higher fasting glucose, post-challenge glucose, insulin levels, and insulin resistance compared to controls. Here, INS is linked to schizophrenia.